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WHAT THIS PAPER ADDS
 Sac growth after endovascular aneurysm repair, reportedly occurring in 40% of patients, is an important ﬁnding which may
inﬂuence prognosis. In case of sac growth and the presence of type II endoleaks or endotension, clipping of side branches and
subsequent sac fenestrationwas suggested in the past as a therapeutic alternative. Long-term efﬁcacy of this procedure is unknown.
The current study provides the single largest case series and longest follow-up after this procedure. Based on our results, sac
fenestration is not advisable as primary treatment in patients suffering from sac growth in the presence of type II endoleaks or
endotension.a r t i c l e i n f o
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Objectives: Sac growth after endovascular aneurysm repair (EVAR) is an important ﬁnding, which may
inﬂuence prognosis. In case of a type II endoleak or endotension, clipping of side branches and subse-
quent sac fenestration has been presented as a therapeutic alternative. The long-term clinical efﬁcacy of
this procedure is unknown.
Methods: The study included eight patients who underwent laparoscopic aortic collateral clipping and
sac fenestration for enlarging aneurysms following EVAR. Secondary interventions and clinical outcome
were retrieved from hospital records. Sac behaviour was evaluated measuring volumes on periodical
computed tomography angiography (CTA) imaging using dedicated software.
Results: Follow-up had a median length of 6.6 (range 0.6e8.6) years. During this time, only three patients
successfully achieved durable aneurysm shrinkage (n ¼ 2) or stability (n ¼ 1). The remaining patients
suffered persistent (n ¼ 2) or recurrent sac growth (n ¼ 3), all regarded as failure of fenestration. A total
of six additional interventions were performed, comprising open conversion (n ¼ 2), relining (n ¼ 1) and
implantation of iliac extensions (n ¼ 3). All additional interventions were successful at arresting further
sac growth during the remainder of follow-up.
Conclusions: Despite being a less invasive alternative to conversion and open repair, the long-term
outcome of sac fenestration is unpredictable and additional major procedures were often necessary to
arrest sac growth.
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aneurysm (AAA) has developed since 19911 and is now frequently
the preferred method of treatment. The ultimate goal of EVAR is to
prevent death from aneurysm rupture by excluding the aneurysmbehalf of European Society for Vascular Surgery. All rights reserved.
Table 1
Descriptive statistics for the study population.
Baseline characteristics All patients (n ¼ 8)
Age in years, median (range) 65.2 (55.1e74.3)
Female gender, n (%) 1 (12.5)
Ischaemic heart disease, n (%) 2 (25)
Diabetes mellitus, n (%) 1 (12.5)
History of stroke, n (%) 0
Congestive heart failure, n (%) 1 (12.5)
Renal dysfunction, n (%) 1 (12.5)
Cardiac arrhythmias, n (%) 1 (12.5)
Hypertension, n (%) 4 (50)
History of smoking, n (%) 3 (37.5)
COPD, n (%) 0
COPD ¼ chronic obstructive pulmonary disease.
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EVAR, most aneurysms will stabilise or shrink in diameter. Some
aneurysms, however, will continue to expand.2e4
Continued sac expansion after EVAR can have several explana-
tions, but endoleaks and graft porosity (endotension) are
frequently cited as culprits. In the case of sac growth, most physi-
cians propose additional treatment to prevent the aneurysm from
rupturing or to prevent aortic dilatation near the proximal or distal
sealing zones, giving rise to possible migration and/or type
I endoleaks. When an endoleak is associated with growth,
a secondary endovascular procedure or conversion to open repair is
usually performed. When no endoleak is found, the solution is
more challenging, as the cause of continued aneurysm expansion is
frequently unclear.
Previously, laparoscopic fenestration of the aneurysm sac was
suggested as treatment for patients with an enlarging aneurysm sac
after EVAR, with clipping of aortic sac collaterals.5 Although the
early results were promising, long-term durability of this treatment
remains unknown. The aim of the current study was to evaluate the
long-term effects of this treatment on sac behaviour, to provide
guidance in future decision making.
Methods
Patient selection
From June 1999 to October 2005, a total of 143 AAA patients
underwent an EVAR procedure in our hospital. During follow-up,
sac growth was observed in 34 patients (23.8%). Type II endoleaks
were detected in 21 cases (14.7%). These were either observed or
treatedwith percutaneous interventions, such as coil-embolisation,
glue injections and endoscopic clipping of lumbar arteries,
depending on sac behaviour. In case of a growing aneurysm sac
where no endoleak was detected or when an endovascular
approach of type II endoleak was technically unsuccessful or failed
to arrest growth, an alternative approach was proposed. Laparo-
scopic fenestration of the aneurysm sac was then performed, which
was preceded by clipping of patent inferior mesenteric artery (AMI)
and lumbar arteries. To evaluate the effect of fenestration on sac
behaviour, all patients who underwent this procedure were
included. The sole exclusion criterion for this study was the lack of
a minimum two post-fenestration imaging studies, as that would
make observations on sac behaviour impossible. The study was
conducted in agreement with the Institutional Medical Ethics
Committee guidelines.
Fenestration procedure
The technical details of this intervention were described previ-
ously.5 In summary, all visible lumbar arteries were clipped endo-
scopically through a retroperitoneal approach, and a patent inferior
mesenteric artery (AMI) was clipped laparoscopically. Cleared from
all patent side branches, the aneurysm was then fenestrated.
During this phase of the operation, the operators could check for
residual back-bleeding and suture any remaining type II endoleaks.
Also, the sac contents were removed at this time and an omentum
slip was inserted whenever technically possible in the sac to
prevent immediate closure of the fenestration, reduce exposure of
the bare endograft to the small intestines and possibly facilitate
resorption of hygroma in the early stages after fenestration.
In one case, the procedure was converted to open suturing of all
patent side branches and fenestration of the sac. The primary
operator during all procedures was the same, experienced vascular
surgeon (J.H.), who was assisted by an experienced laparoscopic
surgeon.Efﬁcacy of fenestration
At the time of these procedures, sac growth was a phenomenon
that was aggressively treated. Therefore, the preferential outcome
of this treatment at the time was to achieve sac stability or
shrinkage. Primary end point of the current study is therefore
persistent or recurrent sac growth, which is considered failure of
treatment. Aneurysm-related death and additional vascular inter-
ventions were recorded as secondary end points. Information on
survival and the cause of death was retrieved from hospital records.
Analysis of sac behaviour
Measurement of the aneurysm sac was performed on computed
tomography angiography (CTA) images. The ﬁrst CTA, within 48 h
after the fenestration,was considered the baseline for future follow-
up. CTAs were then performed approximately every 6e12 months,
according to institutional protocol. All hospital records were
reviewed for additional interventions and rationale behind treat-
ment decisions. Sac behaviour was scored by two complementary
methods.6,7 First, the single largest diameter of the aneurysm sac
was measured. Second, the total sac volumewas quantiﬁed on each
CTA and plotted in time-related curves, regarding the ﬁrst
measurement after fenestration as baseline. Allmeasurementswere
performed on a workstation with dedicated software (3Mensio
Vascular v4.2; 3Mensio Medical Imaging B.V., Bilthoven, The
Netherlands) and using centre-lumen line (CCL) reconstruction.
Volume measurements were obtained according to a standardised
and previously validated protocol.8 Sac growth was deﬁned as >5%
increase in volume compared to baseline or in a 12-month interval.
All data was subsequently analysed using the Statistical Package for
the Social Sciences, version 17.0 (SPSS Inc., Chicago, IL, USA).
Results
Study population
In the presented time window, a total of nine patients with
a growing aneurysm after EVAR underwent aneurysm sac fenes-
tration. One patient died of non-Hodgkin lymphoma 3months after
the procedure, having received only one CTA after the procedure,
and was therefore excluded from the current study. From the
remaining eight patients (seven men), one patient suffered from
a common iliac artery aneurysm rather than an AAA, but was
similarly treated by EVAR and later fenestration for continued
growth. In one patient, the endoscopic procedure was converted to
an open fenestration procedure, as described.5 At the time of
fenestration, the eight patients had a median age of 65.2 (range
55.1e74.3) years. Patient baseline characteristics are detailed in
Table 1. There was no perioperative mortality.
Table 3
Details on fenestration follow-up and outcomes.
Case Baseline
volume
Mid-term
volume
Latest
volume
Follow-up
(years)
Sac
growth
Status
endoleak
Additional
intervention
1 152 81 81 8.6 No n/a None
2 97 97 96 8.6 No Treated Iliac extension
3 263 244 289 8.0 Yes n/a None
4 239 239 263 0.6 Yes Persistent Conversion
5 239 164 151 6.3 No Persistent Iliac extension
6 47 37 43 7.0 Yes n/a Iliac extension
7 188 387 254 6.0 Yes n/a Relining
8 432 381 431 1.3 Yes Persistent Conversion
Volumes are abdominal aneurysm sac volumes in ml. Sac growth was deﬁned as
>5% volume change compared to baseline or in a 12-month interval.
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Four patients were treated with an Excluder AAA Endopros-
thesis (W.L. Gore and associates, Flagstaff, AZ, USA), one of which
was the low-permeability design introduced in 2004 (Table 2). The
remaining implanted grafts were three Zenith AAA Endovascular
Grafts (Cook Medical, Bloomington, IN, USA) and one Ancure Graft
(Guidant, Menlo Park, CA, USA). Fenestration took place at amedian
of 1.7 (range 0.5e5.8) years after EVAR. Pre-fenestration sac
diameters measured on CTA had a median of 73.2 mm (range
56.5e91.0 mm). The indication for fenestration was persistent or
recurrent sac growth for all cases. In 50%, a type II EL could be
detected as the possible culprit (Table 2). Attempts to treat these
ﬁrst with glue injections and coil embolisations had been unsuc-
cessful. Upon reviewing the imaging studies in preparation of the
procedures, no intense inﬂammatory component was observed nor
was this noticed during the operation. During the procedures, the
operators concurred in having achieved proper exposure and the
ability to clip all side branches. As conﬁrmation, in only one case
residual back-bleeding was observed upon opening the aneurysm
sac, which was sutured from within. An omentum slip to leave in
the fenestration was available in ﬁve out of eight patients.
Aneurysm sac behaviour
Follow-up had a median length of 6.6 (range 0.6e8.6) years.
During this time, only three patients experienced durable aneu-
rysm sac shrinkage (n ¼ 2) or stability (n ¼ 1) and were considered
a success. In these three cases where sac growth was successfully
arrested, two cases suffered progression of disease leading to
dilatation of a common iliac artery (Case #2 and #5). Although this
prompted the endovascular extension of one of the distal sealing
zones (Table 3), this was not regarded as failure of fenestration.
The remaining ﬁve cases suffered persistent sac growth (n ¼ 2)
or recurrent growth after initial shrinkage (n ¼ 3), all regarded as
failure of fenestration. The two cases with persistent sac growth
comprised one patient with a persistent type II endoleak despite
clipping and fenestration, who was converted after 6 months (Case
#4), and another patient without detectable endoleaks but an
original design Excluder in situ (Case #7). This patient was
presumed to suffer from endotension, but refused additional
treatment until over 5 years after fenestration, when relining of the
endograft ﬁnally arrested sac growth.
The three cases with recurrent sac growth included one patient
that showed shrinkage during the ﬁrst 7 years, but on the latest CTA
suddenly had growth of the aneurysm sac (Case #3) suggesting re-
pressurisation, and one patient with a persistent type II endoleak
who showed shrinkage at ﬁrst but recurrent growth within 15
months, spurring conversion (Case #8). In the ﬁnal case, primary
indication for EVAR was a combination of a large iliac aneurysm
and a small AAA (Case #6). Sac shrinkage was observed in the ﬁrstTable 2
Details on EVAR follow-up prior to fenestration.
Case Implanted
graft type
Time since
EVAR (years)
Sac diameter
(mm)
Detected
endoleak
1 Excluder OD 1.6 74.7 None
2 Excluder OD 0.7 68.0 Type II
3 Zenith 1.7 83.5 None
4 Zenith 2.6 69.9 Type II
5 Ancure 5.8 71.6 Type II
6 Zenith 2.4 56.5 None
7 Excluder OD 1.6 84.3 None
8 Excluder LP 0.5 91.0 Type II
EVAR¼ endovascular aneurysm repair, OD¼ original design, LP¼ low-permeability
design.two years after fenestration, but eventually volume and diameter
increased again until, ﬁnally, contrast was observed in the iliac
aneurysm sac, resulting in an extension of the distal dealing zone.
No technical aspects of the procedures or observation made
during surgery could be identiﬁed as playing a part in the success
rate of fenestrations. As mentioned earlier, no (untreated) back-
bleeding was observed during the fenestration that could eventu-
ally predispose a patient to a residual or recurrent type II endoleak.
Furthermore, the impossibility to mobilise an omentum slip for
insertion in the fenestration was no predictor for outcome
(arresting growth in two, conversion in one).
In summary, six patients underwent additional interventions
after fenestration. Two patients were converted to open repair, both
suffering from persisting type II endoleaks and early sac (re-)
growth. One patient was relined for persistent sac growth, in the
presence of an original design Excluder endoprosthesis. In addition,
three patients underwent implantation of iliac extensions, one of
which suffered from recurrent iliac sac growth and the other two
from common iliac artery dilatation due to progression of disease.
All secondary interventions after fenestration were successful at
arresting further sac growth during the remaining duration of
follow-up.
Discussion
EVAR has become the preferred method of treatment in many
AAA patients, especially when the aortic anatomy is favourable.
Despite the early survival advantage, EVAR is associated with
greater aneurysm-related complications and therefore most agree
on the need for life-long follow-upwith imaging studies to evaluate
migration, stent integrity, endoleaks and aneurysm size.9e11 Post-
implantation growth has received particular attention because it
is observed with relative frequency and suggests continued pres-
surisation of the aneurysm sac, and therefore failure of treatment
(despite relative rarity in clinical consequences).12 After EVAR, the
majority of patients have either a gradual decline or stabilisation of
their aneurysm dimensions over the years.13 When growth occurs,
however, a plausible explanation should be sought and treatment
promptly offered. While it may be the accepted standard of care
that patients with type I or III endoleaks require rapid intervention,
opinions vary over the implications of type II endoleaks, especially
in cases where the diameter of the aneurysm stabilises or only
grows slowly.14,15 Within the last decade, studies reported that
selective surveillance of a type II endoleak is a safe course.16
Controversially, Jones et al. reported that persistent type II endo-
leak increases the risk for rupture and the need for conversion,17
while data from the EUROSTAR registry suggested that it actually
seems to protect the patient against rupture.14 When the current
patients were diagnosed with a growing aneurysm after EVAR,
endotension and type II endoleaks were aggressively treated. In
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who reached a consensus that growing aneurysms without detec-
tion of endoleaks should be treated surgically or by repeated EVAR
procedure.17 Concerning type II endoleaks, Steinmetz et al. reported
that if no sac growth is seen, no additional intervention is neces-
sary.15 However, general opinion among the leaders previously
mentioned was that persistent type II endoleaks required
treatment, either with coil/glue embolisation18 or laparoscopic
clipping.19
With that historical backdrop, a series of nine patients with
growing aneurysms without detectable endoleaks or with persis-
tent type II endoleaks were treated by laparoscopic clipping of side
branches and aneurysm sac fenestration. Although the short-term
results were promising,5 the current study is the ﬁrst to show
that long-term results are sub-optimal in a large proportion of
patients, raising doubt over the applicability of this previously
described technique. The ultimate goal of the clipping and fenes-
tration procedure was to halt sac growth. Durable aneurysm, sac
stability was only achieved in three patients, two of who under-
went additional procedures for progression of the disease in the
common iliac arteries. Out of the other ﬁve cases, two were con-
verted to open repair, one was relined, one was extended at the
distal sealing zone and one was diagnosed with recurrent sac
growth on the latest scan. In general, the two-step procedure was
not particularly successful in achieving its goal of durable sac
stability.
The ﬁrst step in the procedure was to clip all lumbars and other
possible side branches to treat or prevent type II endoleaks.
Noticeably, out of four cases presenting with a type II endoleak
prior to fenestration in our study, the endoleak persisted in three,
despite the subjectively good view on lumbar arteries during this
procedure. The only successful elimination of a type II endoleakwas
achieved in the one patient that was converted, and therefore
clipping of collaterals and sac fenestration was performed as an
open procedure, reducing the endoscopic success rate of clipping to
nil. Interestingly, an open aneurysm sac with a subsequently
demonstrable endoleak had no clinical consequences in our series.
Although minimally invasive clipping of lumbar side branches has
been frequently performed, right-sided lumbar arteries are tech-
nically difﬁcult to expose and clip.20 In some cases, endoscopic
clipping may be unsuccessful, resulting in residual type II endo-
leaks.21 This could have contributed to the failure of arresting type
II endoleaks durably, in the current study. An alternative approach
is primary fenestration and subsequent sewing of back-bleeding
lumbars from within the sac.22,23
In the current study, fenestration was performed after clipping
of the side branches, allowing for visual control by scanning for
residual back-bleeding, as previously described by Dion et al. in
2001.24 Only in one case, back-bleeding was still observed, and this
was sutured from within the sac. Although sac contents were
thoroughly evacuated after fenestration, the residual type II endo-
leaks could have been masked by mural thrombus or other debris,
missed at the time of surgery. This illustrates that laparoscopic
fenestration is a demanding procedure and, even in the hands of
experienced vascular and laparoscopic surgeons, can lead to
underexposure of the inside of the sac, and thus incomplete
removal of thrombus and assessment of back-bleeding side
branches.
The most logical indication for fenestration would therefore be
endotension as a result of increased graft porosity. Transudate of
ﬂuid through the graft fabric is well described, particularly after
implantation of the original Excluder endograft (W.L. Gore and
associates, Flagstaff, AZ, USA).18 Releasing the hygroma would
theoretically result in arrested growth and prolonged success. This
idea has also been defended by others, both with open19 or withpercutaneous sac fenestration. In our series, two patients implan-
ted with the Original Design Excluder continued to exhibit growth
without detectable endoleaks prior to fenestration. After fenestra-
tion, sac stability was observed in one, but sac growth persisted in
the other, who later underwent successful relining with a low-
permeability graft. This sac growth could be explained by healing
of the fenestration, resulting in the recurrence of hygroma, allowing
re-pressurisation. Goodney et al. and Kougias et al. have published
on their experience with relining, with similar good results at short
term.20,21 This alternative solution, although promising, still lacks
long-term data, but is generally accepted as ﬁrst-line treatment in
case of a growing sac with an original Excluder endograft in situ, or
when graft integrity is thought compromised at a speciﬁc loca-
tion.22,23 Importantly, standard CTA is not the most sensitive
technique for type II endoleak visualisation, and deﬁnite diagnosis
of endotension is often only possible after opening the aneurysm
sac and visualising no bleeding aortic collaterals.25 Therefore, it is
theoretical to reserve this technique for endotension cases.
The current report is limited by its observational design and by
the small number of patients. Also, the indication for treatment was
individualised and no strict criteria were observed, with potential
selection bias. For the purpose of demonstrating the safety and
efﬁcacy of the technique, however, these limitations e albeit
important e can be accepted to prevent others to subject their
patients to this ineffective treatment as well.
In conclusion, the results after fenestration are quite variable
and, more importantly, largely unpredictable. Sac growth was
observed after fenestration in ﬁve out of eight cases, spurring
additional interventions in the majority. Therefore, we cannot
recommend fenestration as primary treatment for sac growth.
Other techniques may holdmore promise whenminimally invasive
interventions fail, risk of rupture is considered high and the patient
is too frail for aortic cross-clamping and endograft explantation.
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